FIELD: medicine.
SUBSTANCE: invention relates to a method for preparation of a selective immunosorbent for removal of antibodies to type 3 desmoglein (Dsg3) from the blood of patients withvesicular fever, including preparation of a Dsg3 solution in a phosphate buffer. Anhydrous NHS-activated agarose is added to the empty centrifuge micro-column, the Dsg3 solution is added to a micro-column with agarose and incubated while mixing; at the end of incubation, the micro-column is centrifuged with cooling, then the resulting filtrate is taken, after which phosphate buffer is added to the column to wash away the unbound Dsg3, centrifuged; the washing procedure is repeated, the filtrates are removed after washing; further, to block the residual active NHS groups of the sorbent, a buffer solution of ethanolamine is added and incubated while mixing; after the incubation is completed, it is centrifuged, the filtrate is removed; the washing procedure is repeated, the filtrates are removed after washing; the ready-made sorbent is used to isolate autoantibodies to Dsg3.
EFFECT: production of selective immunosorbent for selective removal of antibodies to type 3 desmoglein from serum in patients with vesicular fever.
4 dwg, 1 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING SELECTIVE IMMUNOSORBENT FOR REMOVAL OF ANTIBODIES-IgG TO DESMOGLEIN OF TYPE 3 FROM BLOOD SERUM OF PATIENTS WITH PEMPHIGUS | 2015 |
|
RU2622005C2 |
PEMPHIGUS SIMULATION METHOD FOR MICE BY IMMUNOGLOBULIN G ADMINISTRATION | 2015 |
|
RU2613718C1 |
RECOMBINANT ANTIGEN PROTEINS AND METHOD FOR DETERMINING THE EPITOPIC SPECIFICITY OF AUTOREACTIVE ANTIBODIES TO INDIVIDUAL FRAGMENTS OF THE EXTRACELLULAR DOMAIN OF HUMAN DESMOGLEIN-3 IN PATIENTS WITH PEMPHIGUS VULGARIS, TEST SYSTEM BASED THEREON | 2021 |
|
RU2770444C1 |
PREPARATIONS, CONTAINING ANTIBODIES AGAINST Fas LIGAND, FOR TREATING PEMPHIGUS | 2009 |
|
RU2556818C2 |
METHOD FOR PREDICTION OF VARIABILITY OF PEMPHIGUS CLINICAL FORM | 2008 |
|
RU2386400C1 |
MEDICATIONS FOR TREATING PEMPHIGUS CONTAINING ANTIBODIES TO Fas-LIGAND | 2008 |
|
RU2558260C2 |
METHOD FOR PREDICTING COURSE OF ISOLATED FORM OF ACANTHOLYTIC PERVASIVE CAVITY | 2018 |
|
RU2688209C1 |
METHOD FOR PREDICTION OF CLINICAL COURSE OF AUTOIMMUNE PEMPHIGUS | 2010 |
|
RU2429482C1 |
IMMUNOGLOBULIN REMOVING SORBENT | 2006 |
|
RU2325172C2 |
METHOD OF FREEING BLOOD FROM RHEUMATOID FACTOR | 1991 |
|
RU2027192C1 |
Authors
Dates
2017-08-09—Published
2016-07-18—Filed